Delivery Order SPE2DR25D7068-SPE2DR26F5BR1
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). The contract, valued at $2,760.16, represents a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.16 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract, which is firm fixed price with an ultimate completion date of April 24, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,790.18 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with completion due by July 31, 2025. This firm fixed-price, non-set-aside contract calls for the delivery of Atovaquone-Proguanil 250-100 mg unit dose packages in quantities of 24, a combination antimalarial medication used primarily for malaria prophylaxis and treatment in military and veteran...
- The Defense Logistics Agency awarded a $44,740.80 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs the work at its corporate office location. The delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract ceiling value of $3,665.97. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for May 21, 2025, and performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $9,466.11 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with a firm fixed price structure. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by September 8, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $6,844.74 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100 count) on October 16, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count), valued at $6,446.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 27, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BR1Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 24, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in quantities of 100 units, with a ceiling value of $19,475.42. The contract employs firm fixed price pricing and has an ultimate completion date of November 25, 2025. This award is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA encompasses a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for Atovaquone-Proguanil—an antimalarial medication—represents one of numerous pharmaceutical deliveries the company fulfills under its comprehensive global pharmaceutical support vehicle, which enables supply of medications, vaccines, syringes, and specialized medical commodities to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 11/23/25 |